Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levodopa failure in chronic manganism

C S Lu1, C C Huang, N S Chu

  • 1Department of Neurology, Chang Gung Medical College and Memorial Hospital, Taipei, Taiwan.

Neurology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The object technology framework: an object-oriented interface to molecular data and its application to collagen.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·1998
Same author

Oxygen, arterial blood gases and ventilation are unchanged during dialysis in patients receiving pressure support ventilation.

Respiratory medicine·1998
Same author

Perinatal hypoxic/ischemic encephalopathy: clinical challenge and experimental implications.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui·1998
Same author

Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan.

Journal of toxicology and environmental health. Part A·1998
Same author

Subdural empyema in 10 infants: US characteristics and clinical correlates.

Radiology·1998
Same author

X-linked recessive bulbospinal neuronopathy: clinical and molecular studies in a Taiwanese family.

Journal of the Formosan Medical Association = Taiwan yi zhi·1998
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Levodopa did not improve parkinsonism or dystonia in patients with chronic manganese intoxication. This double-blind study found no sustained benefit from the drug in treating these neurological deficits.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Chronic manganese intoxication can lead to persistent extrapyramidal deficits, including parkinsonism and dystonia.
  • These neurological symptoms may continue to progress for years after cessation of exposure.

Purpose of the Study:

  • To evaluate the efficacy of levodopa in treating parkinsonism and dystonia resulting from chronic manganese intoxication.

Main Methods:

  • A placebo-controlled, double-blind study was conducted.
  • Four patients with established extrapyramidal deficits from manganese exposure participated.

Main Results:

  • Initial open-label observations suggested a possible response to levodopa.
  • However, the double-blind phase demonstrated a lack of sustained therapeutic benefit.

Related Experiment Videos

  • Patients' parkinsonism and dystonia did not respond to levodopa treatment.

    • Conclusions:

    • Levodopa is ineffective in treating the parkinsonism and dystonia associated with chronic manganese intoxication.
    • Further research may be needed to explore alternative therapeutic strategies for manganese-induced neurological damage.